Fecal Microbiota Therapy: Ready for Prime Time?

Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

(2013) Lauren M. De Leon et al.   Clinical Gastroenterology and Hepatology

Poor Functional Status as a Risk Factor for SevereClostridium difficileInfection in Hospitalized Older Adults

(2013) Krishna Rao et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin

(2012) I. Figueroa et al.   CLINICAL INFECTIOUS DISEASES

Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection

(2011) Ethan Gough et al.   CLINICAL INFECTIOUS DISEASES

A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection

(2011) K. W. Garey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score

(2011) M.R. Welfare et al.   JOURNAL OF HOSPITAL INFECTION

Gut Microbiota in Health and Disease

(2010) Inna Sekirov et al.   PHYSIOLOGICAL REVIEWS

Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated Diarrhea

(2008) Ju Young Chang et al.   JOURNAL OF INFECTIOUS DISEASES

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

(2008) Marc GH Besselink et al.   LANCET